Cheng Fang is a neuroscientist with a keen business mindset, specializing in drug research and clinical development for neurodegenerative diseases. She possesses a decade of experience in conditions such as Prion Diseases, Alzheimer's Disease, Multiple Sclerosis, and Huntington's disease.

Her expertise includes designing and leading clinical development, guiding projects from IND to phase 2 and 3 clinical trials, particularly in Alzheimer's and Parkinson's disease.